Association of African-American Ethnic Background With Survival in Men With Metastatic Prostate Cancer
Open Access
- 7 February 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 93 (3) , 219-225
- https://doi.org/10.1093/jnci/93.3.219
Abstract
Background: African-American men have earlier onset of prostate cancer, higher prostate-specific antigen (PSA) levels, more advanced stage at diagnosis, and higher mortality than white men. It is not known whether the poorer survival of African-American men with prostate cancer reflects their later stage at diagnosis or differences in the basic biology of their disease. To evaluate this question, we examined outcomes of African-American and white men with metastatic prostate cancer in the context of a randomized clinical trial. Methods: Southwest Oncology Group Study 8894 was a randomized phase III trial that compared orchiectomy with or without flutamide in men with metastatic prostate cancer. Using data from 288 African-American and 975 white men in the trial, we conducted a proportional hazards regression analysis to determine if ethnicity was an independent predictor of survival. All statistical tests were two-sided. Results: African-American men were more likely than white men to have extensive disease and bone pain and had poorer performance status, younger age at study entry, higher Gleason score, and higher PSA levels. After adjustment for these prognostic variables, the hazard ratio (HR) for all-cause mortality for African-American men relative to white men was 1.23 (P = .018). Further adjustment for initial quality-of-life assessments also resulted in higher HRs associated with African-American ethnicity relative to white ethnicity (HR = 1.39; P = .007). Conclusions: African-American men with metastatic prostate cancer have a statistically significantly worse prognosis than white men that cannot be explained by the prognostic variables explored in this study. These data should give increased impetus for efforts to detect the disease early in African-American men and for the development of more effective therapies based on potential biologic differences in this ethnic group.Keywords
This publication has 16 references indexed in Scilit:
- Prostate cancer: demographic and behavioral correlates of stage at diagnosis among blacks and whites in North CarolinaUrology, 1999
- Should African-American men be tested for prostate carcinoma at an earlier age than white men?Cancer, 1999
- Quality of Life in Advanced Prostate Cancer: Results of a Randomized Therapeutic TrialJNCI Journal of the National Cancer Institute, 1998
- Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate CancerNew England Journal of Medicine, 1998
- Cause of death in men diagnosed with prostate carcinomaCancer, 1998
- Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer.Journal of Clinical Oncology, 1998
- Race, prostate cancer survival, and membership in a large health maintenance organization.JNCI Journal of the National Cancer Institute, 1998
- ACS Sets Blueprint for Action Against Prostate Cancer in African AmericansJAMA, 1998
- Recruitment of African Americans into prostate cancer screening.Cancer Practice, 1998
- Survival in Blacks and Whites After Treatment for Localized Prostate CancerJournal of Urology, 1996